Immunomodulation in COVID-19
Review discusses potential benefits of interleukin-6 inhibition over the repurposing of approved drugs that directly limit viral replication.
Source:
The Lancet Respiratory Medicine
Review discusses potential benefits of interleukin-6 inhibition over the repurposing of approved drugs that directly limit viral replication.
The Lancet Respiratory Medicine